These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21596039)

  • 1. Role of myelin-associated inhibitors in axonal repair after spinal cord injury.
    Lee JK; Zheng B
    Exp Neurol; 2012 May; 235(1):33-42. PubMed ID: 21596039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice.
    Lee JK; Geoffroy CG; Chan AF; Tolentino KE; Crawford MJ; Leal MA; Kang B; Zheng B
    Neuron; 2010 Jun; 66(5):663-70. PubMed ID: 20547125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma.
    Cafferty WB; Duffy P; Huebner E; Strittmatter SM
    J Neurosci; 2010 May; 30(20):6825-37. PubMed ID: 20484625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo on the go.
    McKerracher L; Winton MJ
    Neuron; 2002 Oct; 36(3):345-8. PubMed ID: 12408839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity.
    Akbik F; Cafferty WB; Strittmatter SM
    Exp Neurol; 2012 May; 235(1):43-52. PubMed ID: 21699896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory proteins against axon regeneration in the central nervous system].
    Hu JG; Lu PH; Xu XM
    Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
    Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
    J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for myelin inhibitors: Structures and therapeutic opportunities.
    Cao Z; Gao Y; Deng K; Williams G; Doherty P; Walsh FS
    Mol Cell Neurosci; 2010 Jan; 43(1):1-14. PubMed ID: 19619659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.
    Giger RJ; Venkatesh K; Chivatakarn O; Raiker SJ; Robak L; Hofer T; Lee H; Rader C
    Restor Neurol Neurosci; 2008; 26(2-3):97-115. PubMed ID: 18820405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D; Coffin RS; Anderson PN
    J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular approaches to spinal cord repair.
    David S; Lacroix S
    Annu Rev Neurosci; 2003; 26():411-40. PubMed ID: 12626698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin-associated inhibitors in axonal growth after CNS injury.
    Geoffroy CG; Zheng B
    Curr Opin Neurobiol; 2014 Aug; 27():31-8. PubMed ID: 24608164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression pattern of Nogo-A, MAG, and NgR in regenerating urodele spinal cord.
    Hui SP; Monaghan JR; Voss SR; Ghosh S
    Dev Dyn; 2013 Jul; 242(7):847-60. PubMed ID: 23592243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PirB is a functional receptor for myelin inhibitors of axonal regeneration.
    Atwal JK; Pinkston-Gosse J; Syken J; Stawicki S; Wu Y; Shatz C; Tessier-Lavigne M
    Science; 2008 Nov; 322(5903):967-70. PubMed ID: 18988857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration.
    Lee JK; Chow R; Xie F; Chow SY; Tolentino KE; Zheng B
    J Neurosci; 2010 Aug; 30(32):10899-904. PubMed ID: 20702718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve regeneration: regrowth stumped by shared receptor.
    Watkins TA; Barres BA
    Curr Biol; 2002 Oct; 12(19):R654-6. PubMed ID: 12361584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic DNA vaccination as a repair strategy following spinal cord injury.
    Kou SB; Xu G; Jiang XD; Xu RX; Tang YP; Xu G; Cai YQ; Du MX; Xiao ZC
    Cell Mol Neurobiol; 2010 Mar; 30(2):275-82. PubMed ID: 19757023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo domains and a Nogo receptor: implications for axon regeneration.
    Brittis PA; Flanagan JG
    Neuron; 2001 Apr; 30(1):11-4. PubMed ID: 11343640
    [No Abstract]   [Full Text] [Related]  

  • 20. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.